← Open Payments lookup

KYLEE PULSIPHER: Open Payments

NPI 1528609880 · SANDY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,976 in 97 payments from 21 companies in 2025. Trend: 2023 $771 · 2024 $1,998 · 2025 $1,976

Food & beverage: $1,976
CompanyPaymentsAmount
ABBVIE INC.14$261
Neurocrine BioSciences, Inc.10$223
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$183
Takeda Pharmaceuticals U.S.A., Inc.5$143
Alkermes, Inc.7$141
Vanda Pharmaceuticals Inc.5$138
Janssen Pharmaceuticals, Inc8$138
Otsuka America Pharmaceutical, Inc.6$131
Tris Pharma Inc5$106
Lundbeck LLC5$103

Products named: VRAYLAR, INGREZZA, REXULTI, CAPLYTA, TRINTELLIX, FANAPT, ARISTADA, Dyanavel XR.

Industry payments across UT — which companies pay providers there.